$0
President and Chief Executive Officer
2024
President and Chief Executive Officer at Cure Rare Foundation
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Jessica Linderman has been listed as an employee of Cure Rare Foundation in Form 990 filings since fiscal year 2023.